Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190121042444N3

Enrollment

Registered

2020-07-04

Start date

2020-02-20

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. U07.1 COVID posetive

Interventions

Intervention 1: In this study, randomly placed in a group of patients with desferal supplementation at a dose of 20 to 60 mg by weight over 8 to 12 hours, along with 100 mg of vitamin C ampoules at th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Get infected with a viral infection COVID-19 High serum ferritin levels Increased inflammatory factor in the blood

Exclusion criteria

Exclusion criteria: Patients with renal insufficiency Consumption of desferal supplementary in them is contraindicated

Design outcomes

Primary

Measure	Time frame
CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement.;CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaranak Behnaz

Shahid Beheshti University of Medical Sciences

faranak.behnaz@gmail.com+98 21 2274 1174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026